Recent Advances in Crystalline Polymorphism Research in Drug Development

Webinar Date: May 15, 2026
Time: 11:00 AM EDT
Duration: 1 Hour
  • <<
  • >>

This webinar explores recent advancements in crystal screening and characterization for pharmaceutical development. In the first segment, researchers from NGK Corporation outline a new crystal polymorphism screening approach that utilizes infrared radiation technology to enhance the detection of previously unidentified crystalline forms. Experimental case studies will illustrate how this method can support more reliable and efficient drug development. In the second segment, Professor Etsuo Yonemochi from the International University of Health and Welfare will discuss the relationship between crystallization conditions and crystal morphology, examining how these factors influence properties such as dissolution, wettability, and manufacturability. His presentation will also cover the use of molecular simulations to assess formulation-related characteristics.

This webinar will provide:

  • Introduction of NGK’s novel crystal polymorphism screening service, which applies proprietary infrared radiation technology to enhance the discovery of previously unknown crystalline forms.
  • Practical experimental case studies demonstrating how infrared based screening can complement conventional polymorphism screening approaches and support more robust drug development.
  • Fundamental understanding of pharmaceutical crystal morphology, including how crystallization conditions influence crystal habit and surface growth behavior.
  • Insights into the impact of crystal morphology on formulation properties, such as wettability, dissolution behavior, flowability, and tabletability during pharmaceutical manufacturing.
  • Advanced evaluation approaches using molecular simulations, illustrating how crystal structure data can be applied to predict and assess formulation relevant physicochemical properties.

Who should attend: 

  • Researchers engaged in physical properties research
  • Analytical researchers
  • Process researchers
  • Scientists and professionals in drug discovery

Register Now

  • Please complete the following information to register for this webinar. If you already have an account, and the information will be filled out for you.
  • The webinar sponsors and American Pharmaceutical Review may use the information you have provided to contact you about this webinar and other related topics. For more information please refer to our privacy policy.
Professor, School of Pharmacy at Narita
International University of Health and Welfare
Manager, Crystal Polymorphism Group, Corporate NV Creation
NGK Corporation
Image Mike Auerbach
Editor-in-Chief
American Pharmaceutical Review